Pharma Marketing Blog represents the opinions of
John Mack
Publisher of
Pharma Marketing News.
We accept advertising relevant to the interests of our members.
For more information, see:
Operated by:
VirSci Corporation
PO Box 760
Newtown, PA 18940
215-504-4164
215-504-5739 (FAX)
E-mail: infovirsci@virsci.com
My Humble Opinion
|
Other People's Opinion
|
| A "Must Read" Blog for Insiders. -- Wall Street Journal | A bi-weekly podcast. Listen and call-in live online or download to your iPod! |
| Also see Pharma Marketing News OpEd Pieces |
Web 2.0 Hates SallyPosted: April 5, 2007Sally Field is all over the TV these days hawking Boniva. One night she's talking about her own experience with osteoporosis and the next she's talking about "her friend." The FTC soon may have a thing or two to say about celebrity spokespersons, especially those who do not reveal that they are being paid to mention drug names on talk shows. Yet, the FTC has traditionally ceded oversight of drug ads and promotions to the FDA and that may give the drug industry a free pass. Web 2.0 (aka, social networking) is not as forgiving as the FDA or maybe even the FTC regarding the antics of Rx brand celebrity spokespeople like Sally Field. To see what I mean and find out the two questions I would ask a branded Rx spokesperson, see today's post to Pharma Marketing Blog. For more posts in related topic areas, see: If you wish to receive notice by email whenever a post is made to Pharma Marketing Blog, please subscribe.
|
Special Supplement ePharma Marketing
The selection of articles in this Special Supplement to Pharma Marketing News was chosen to give you a better perspective on pharma eMarketing. Included are real world case studies that illustrate the advantages of eMarketing such as depth of information, interaction, relationship building and superior customer engagement.
Order and pay for this Special Supplement now using your credit card ONLY $29.95
If you wish to pay by check or credit card off-line, please use: |
